1,302
Views
1
CrossRef citations to date
0
Altmetric
Report

Affinity-controlled capture and release of engineered monoclonal antibodies by macroporous dextran hydrogels using coiled-coil interactions

, , , , , , , , & ORCID Icon show all
Article: 2218951 | Received 29 Jan 2023, Accepted 24 May 2023, Published online: 10 Jun 2023

References

  • Castelli MS, McGonigle P, Hornby PJ. The pharmacology and therapeutic applications of monoclonal antibodies. Pharmacol Res Perspect. 2019;7(6):e00535. doi:10.1002/prp2.535.
  • Yamada T. Therapeutic monoclonal antibodies. Keio J Med. 2011;60(2):37–18. doi:10.2302/kjm.60.37.
  • Jin S, Sun Y, Liang X, Gu X, Ning J, Xu Y, Chen S, Pan L. Emerging new therapeutic antibody derivatives for cancer treatment. Sig Transduct Target Ther. 2022;7:39. doi:10.1038/s41392-021-00868-x.
  • Schellekens H. Bioequivalence and the immunogenicity of biopharmaceuticals. Nat Rev Drug Discov. 2002;1:457–62. doi:10.1038/nrd818.
  • Cui Y, Cui P, Chen B, Li S, Guan H. Monoclonal antibodies: formulations of marketed products and recent advances in novel delivery system. Drug Dev Ind Pharm. 2017;43(4):519–30. doi:10.1080/03639045.2017.1278768.
  • Wang W, Wang EQ, Balthasar JP. Monoclonal antibody pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther. 2008;84:548–58. doi:10.1038/clpt.2008.170.
  • Huynh V, Wylie RG. Competitive affinity release for long-term delivery of antibodies from hydrogels. Angew Chem Int Ed Engl. 2018;57(13):3406–10. doi:10.1002/anie.201713428.
  • Chen M, Ouyang H, Zhou S, Li J, Ye Y. PLGA-nanoparticle mediated delivery of anti-OX40 monoclonal antibody enhances anti-tumor cytotoxic T cell responses. Cell Immunol. 2014;287(2):91–99. doi:10.1016/j.cellimm.2014.01.003.
  • Fletcher NA, Babcock LR, Murray EA, Krebs MD. Controlled delivery of antibodies from injectable hydrogels. Mater Sci Eng C Mater Biol Appl. 2016;59:801–06. doi:10.1016/j.msec.2015.10.096.
  • Booth BA, Vidal Denham L, Bouhanik S, Jacob JT, Hill JM. Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications. Drugs Aging. 2007;24(7):581–602. doi:10.2165/00002512-200724070-00006.
  • Huynh V, Jesmer AH, Shoaib MM, D’Angelo AD, Rullo AF, Wylie RG. improved efficacy of antibody cancer immunotherapeutics through local and sustained delivery. Chembiochem. 2019;20:747–53. doi:10.1002/cbic.201800579.
  • Cirillo G, Spizzirri UG, Curcio M, Nicoletta FP, Iemma F. Injectable hydrogels for cancer therapy over the last decade. Pharmaceutics. 2019;9:11. doi:10.3390/pharmaceutics11090486.
  • De France KJ, Xu F, Hoare T. Structured macroporous hydrogels: progress, challenges, and opportunities. Adv Healthcare Mater. 2018;7(1):1700927. doi:10.1002/adhm.201700927.
  • Dinu MV, ES D. Macroporous hydrogels: preparation, properties, and applications. In: Thakur V Thakur M, editors. Hydrogels: Recent advances. Singapore:Springer Singapore; 2018. pp. 51–85. 10.1007/978-981-10-6077-9_3
  • Oliverio R, Patenaude V, Liberelle B, Virgilio N, Banquy X, De Crescenzo G. Macroporous dextran hydrogels for controlled growth factor capture and delivery using coiled-coil interactions. Acta Biomater. 2022. doi:10.1016/j.actbio.2022.09.020.
  • Carasso LS, Benhar I, Dvir T. Universal biofactor-releasing scaffold enabling in vivo reloading. Nano Lett. 2019;19(3):1838–43. doi:10.1021/acs.nanolett.8b04927.
  • Utterstrom J, Naeimipour S, Selegard R, Aili D. Coiled coil-based therapeutics and drug delivery systems. Adv Drug Deliv Rev. 2021;170:26–43 doi:10.1016/j.addr.2020.12.012.
  • Abune L, Wang Y. Affinity hydrogels for protein delivery. Trends Pharmacol Sci. 2021;42:300–12. doi:10.1016/j.tips.2021.01.005.
  • Vulic K, Shoichet MS. Tunable growth factor delivery from injectable hydrogels for tissue engineering. J Am Chem Soc. 2012;134(2):882–85. doi:10.1021/ja210638x.
  • Abune L, Zhao N, Lai J, Peterson B, Szczesny S, Wang Y. Macroporous hydrogels for stable sequestration and sustained release of vascular endothelial growth factor and basic fibroblast growth factor using nucleic acid aptamers. ACS Biomaterials Science & Engineering. 2019;5(5):2382–90. doi:10.1021/acsbiomaterials.9b00423.
  • Huynh V, Wylie RG. Competitive affinity release for long‐term delivery of antibodies from hydrogels. Angewandte Chemie International Edition. 2018;57(13):3406–10. doi:10.1002/anie.201713428.
  • Huynh V, Wylie RG. Displacement affinity release of antibodies from injectable hydrogels. ACS Appl Mater Interfaces. 2019;11(34):30648–60. doi:10.1021/acsami.9b12572.
  • Mason JM, Arndt KM. Coiled coil domains: stability, specificity, and biological implications. Chembiochem. 2004;5:170–76. doi:10.1002/cbic.200300781.
  • Litowski JR, Hodges RS. Designing heterodimeric two-stranded α-helical coiled-coils. J Biol Chem. 2002;277(40):37272–79. doi:10.1074/jbc.M204257200.
  • Apostolovic B, Danial M, Klok HA. Coiled coils: attractive protein folding motifs for the fabrication of self-assembled, responsive and bioactive materials. Chem Soc Rev. 2010;39(9):3541–75. doi:10.1039/b914339b.
  • Truebestein L, TA L. Coiled-coils: the long and short of it. Bioessays. 2016;38(9):903–16. doi:10.1002/bies.201600062.
  • Woolfson DN. Coiled-coil design: updated and upgraded. Subcell Biochem. 2017;82:35–61 doi:10.1007/978-3-319-49674-0_2.
  • Surkont J, Pereira-Leal JB. Evolutionary patterns in coiled-coils. Genome Biol Evol. 2015;7(2):545–56. doi:10.1093/gbe/evv007.
  • Raymond C, Robotham A, Spearman M, Butler M, Kelly J, Durocher Y. Production of α2,6-sialylated IgG1 in CHO cells. MAbs. 2015;7(3):571–83. doi:10.1080/19420862.2015.1029215.
  • Liu H, Gaza-Bulseco G, Chumsae C, Newby-Kew A. Characterization of lower molecular weight artifact bands of recombinant monoclonal IgG1 antibodies on non-reducing SDS-PAGE. Biotechnol Lett. 2007;29(11):1611–22. doi:10.1007/s10529-007-9449-8.
  • Zhang Y, Wang Y, Li Y. Major cause of antibody artifact bands on non-reducing SDS-PAGE and methods for minimizing artifacts. Protein Expr Purif. 2019;164:105459. doi:10.1016/j.pep.2019.105459.
  • Zhu ZC, Chen Y, Ackerman MS, Wang B, Wu W, Li B, Obenauer-Kutner L, Zhao R, Tao L, Ihnat PM. Investigation of monoclonal antibody fragmentation artifacts in non-reducing SDS-PAGE. J Pharmaceut Biomed. 2013;83:89–95. doi:10.1016/j.jpba.2013.04.030.
  • Stenberg E, Persson B, Roos H, Urbaniczky C. Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins. J Colloid Interface Sci. 1991;143:513–26. doi:10.1016/0021-9797(91)90284-F.
  • De Crescenzo G, Litowski JR, Hodges RS, O’Connor-McCourt MD. Real-time monitoring of the interactions of two-stranded de novo designed coiled-coils: effect of chain length on the kinetic and thermodynamic constants of binding. Biochemistry. 2003;42:1754–63. doi:10.1021/bi0268450.
  • Fernandez-Rodriguez J, Marlovits TC. Induced heterodimerization and purification of two target proteins by a synthetic coiled-coil tag. Protein Sci. 2012;21(4):511–19. doi:10.1002/pro.2035.
  • Murschel F, Liberelle B, St-Laurent G, Jolicoeur M, Durocher Y, De Crescenzo G. Coiled-coil-mediated grafting of bioactive vascular endothelial growth factor. Acta Biomater. 2013;9(6):6806–13. doi:10.1016/j.actbio.2013.02.032.
  • Trang VH, Zhang X, Yumul RC, Zeng W, Stone IJ, Wo SW, Dominguez MM, Cochran JH, Simmons JK, Ryan MC, et al. A coiled-coil masking domain for selective activation of therapeutic antibodies. Nat Biotechnol. 2019;37(7):761–65. doi:10.1038/s41587-019-0135-x.
  • Pina AS, Lowe CR, Roque AC. Challenges and opportunities in the purification of recombinant tagged proteins. Biotechnol Adv. 2014;32(2):366–81. doi:10.1016/j.biotechadv.2013.12.001.
  • Lienqueo ME, Salazar O, Calado CR, Fonseca LP, Cabral JM. Influence of tryptophan tags on the purification of cutinase, secreted by a recombinant Saccharomyces cerevisiae, using cationic expanded bed adsorption and hydrophobic interaction chromatography. Biotechnol Lett. 2008;30:1353–58. doi:10.1007/s10529-008-9696-3.
  • Bernier SC, Cantin L, Salesse C. Systematic analysis of the expression, solubility and purification of a passenger protein in fusion with different tags. Protein Expr Purif. 2018;152:92–106. doi:10.1016/j.pep.2018.07.007.
  • Gerling-Driessen UI, Mujkic-Ninnemann N, Ponader D, Schöne D, Hartmann L, Koksch B, Gerling-Driessen UI, Schöne D, Koksch B, Ponader D, et al. Exploiting oligo(amido amine) backbones for the multivalent presentation of coiled-coil peptides. Biomacromolecules. 2015;16(8):2394–402. doi:10.1021/acs.biomac.5b00634.
  • Apostolovic B, Klok HA. Ph-sensitivity of the E3/K3 heterodimeric coiled coil. Biomacromolecules. 2008;9:3173–80. doi:10.1021/bm800746e.
  • Murschel F, Fortier C, Jolicoeur M, Hodges RS, De Crescenzo G. Two complementary approaches for the controlled release of biomolecules immobilized via coiled-coil interactions: peptide core mutations and multivalent presentation. Biomacromolecules. 2017;18:965–75. doi:10.1021/acs.biomac.6b01830.
  • Durocher Y, Perret S, Kamen A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 2002;30:E9. doi:10.1093/nar/30.2.e9.
  • Dorion-Thibaudeau J, Raymond C, Lattová E, Perreault H, Durocher Y, De Crescenzo G. Towards the development of a surface plasmon resonance assay to evaluate the glycosylation pattern of monoclonal antibodies using the extracellular domains of CD16a and CD64. J Immunol Methods. 2014;408:24–34. doi:10.1016/j.jim.2014.04.010.
  • Dorion‐Thibaudeau J, St‐Laurent G, Raymond C, De Crescenzo G, Durocher Y. Biotinylation of the Fcγ receptor ectodomains by mammalian cell co‐transfection: application to the development of a surface plasmon resonance‐based assay. Journal Of Molecular Recognition. 2016;29(2):60–69. doi:10.1002/jmr.2495.
  • Delafosse L, Xu P, Durocher Y. Comparative study of polyethylenimines for transient gene expression in mammalian HEK293 and CHO cells. J Biotechnol. 2016;227:103–11. doi:10.1016/j.jbiotec.2016.04.028.
  • Presolski SI, Hong VP, Finn M. Copper‐catalyzed azide–alkyne click chemistry for bioconjugation. Curr Protoc Chem Biol. 2011;3:153–62. doi:10.1002/9780470559277.ch110148.